Prediction: This Healthcare Stock Could Soar by 72% in 2026 [Yahoo! Finance]
Abivax SA (ABVX)
Company Research
Source: Yahoo! Finance
If the biotech gets acquired this year, its shares could soar. 10 stocks we like better than Abivax Société Anonyme › Abivax (NASDAQ: ABVX) , a France-based biotech, saw its shares skyrocket by more than 1,740% last year after it made significant progress with its leading pipeline drug candidate, obefazimod. However, the stock may not have peaked yet. There is a reason to believe the stock could soar another 72% this year. Obefazimod would be entering a crowded market. It is being developed to treat ulcerative colitis (UC), an area currently dominated by some of the largest pharmaceutical companies . Many current UC therapies work by suppressing part of the body's immune response that causes chronic inflammation. These are effective, but they can also weaken patients' immune systems and increase their risk of other illnesses, especially when used over prolonged periods. Obefazimod works differently. It is being presented as a UC medicine that can control symptoms of the dis
Show less
Read more
Impact Snapshot
Event Time:
ABVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABVX alerts
High impacting Abivax SA news events
Weekly update
A roundup of the hottest topics
ABVX
News
- Abivax (ABVX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $160.00 price target on the stock.MarketBeat
- Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year [Yahoo! Finance]Yahoo! Finance
- 2 Reasons Abivax Stock Could 10X by 2036 [Yahoo! Finance]Yahoo! Finance
- Abivax (ABVX) had its "buy" rating reaffirmed by BTIG Research. They now have a $150.00 price target on the stock.MarketBeat
- Abivax (NASDAQ:ABVX) is now covered by analysts at Wedbush. They set an "underperform" rating on the stock.MarketBeat